Navigation Links
Once-Daily Cipro(R) XR for Treating Complicated Urinary Tract Infections

Urinary tract infections (UTI) are often caused by bacteria and are frequently treated with antibiotics, such as fluoroquinolones. Fluoroquinolones have been recommended empirical therapy for treatment of complicated UTIs. Research indicates that Ciprofloxacin has high activity against E. coli that causes the majority of these infections. This new extended release formulation of ciprofloxacin may provide a convenient// once-daily treatment option for these difficult-to treat infections. The once-daily formulation enables the rapid release of ciprofloxacin, which distributes to the serum and tissues within hours. This is followed by a second extended release of the active ingredient, which produces 24-hour urine concentrations.

Research study compared 1000mg once-daily Cipro XR to a twice-daily 500 mg dose of conventional Cipro. Patients were evaluated based on the presence of UTI. Evaluation was based on bacteriologic and clinical outcomes. Bacteriological eradication was achieved in 89 percent of patients treated with once-daily Cipro XR and 85 percent of patients treated with conventional twice-daily Cipro. Clinical cure was observed in 97 percent of patients treated once a day with Cipro XR 1000mg, compared with 94 percent of patients receiving the traditional Cipro 500mg twice daily. This indicates safety and efficacy profile of once-daily Cipro(R) XR is Comparable to Conventional CIPRO(R) in treating Complicated Urinary Tract Infections.
'"/>




Page: 1

Related medicine news :

1. Treating eye pain eases migraine
2. Treating wounds without stitches
3. Treating varicose veins
4. Treating acne with laser
5. Treating Stroke Patients in Rural Areas
6. Free Tissue Transfer Effective in Treating Massive Skin Cancers
7. Treating Blocked Arteries In The Lower Limbs
8. Zinc Supplements Found To Be Effective In Treating Children With ADHD
9. Hormone Leptin Found To Be Effective In Treating Women With Infertility Problems
10. Treating Depression In Children Could Lead To Poor Bone Development
11. The Effect Of Pain Relievers In Treating Kids With Migraine Questioned
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/20/2017)... Houston, Texas (PRWEB) , ... July 20, 2017 ... ... and litigation law firm headquartered in Houston, is pleased to announce their expansion ... decades of affordable housing experience, directors Alysse Hollis and Ronald Bell, and of ...
(Date:7/20/2017)... ... ... Team Type 1 Foundation, a nonprofit organization pursuing a global mission of ... up with a Microsoft Corp. employee-led hackathon team for the 2017 Microsoft One Week ... Type 1’s mission overlaps seamlessly with Microsoft’s mission to empower every person and every ...
(Date:7/20/2017)... ... 20, 2017 , ... Girl Up Campaign Director, Melissa Kilby, ... in support of providing girls access to education in refugee settings. In May, Congressman ... Girls’ Access to Education in Vulnerable Settings Act.” Yesterday, companion legislation was introduced ...
(Date:7/20/2017)... Lake, Wisconsin (PRWEB) , ... July 20, 2017 ... ... release of two products that further expand its existing adherence automation lines. The ... solutions that mirror the advanced technology of TCG’s standard products, but at a ...
(Date:7/20/2017)... ... July 20, 2017 , ... With ... 2014, top travel insurance solution company VisitorsCoverage Inc. has launched TMQuotes, a new ... international travel insurance products online, under their own brand. The online marketplace bridges ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... 10, 2017  The tenth annual BioPharm America™ ... at the Sheraton Boston Hotel, September 26–27. ... to global decision makers and innovative biotech startup companies. ... leaders during two impactful days. BioPharm America is now ... additional networking opportunities with 4,500+ life science industry influencers ...
(Date:7/5/2017)... 2017 Wolfmet 3D  printed tungsten collimator manufactured by M&I ... manufacturing combine to progress molecular radiotherapy imaging. In ... unable to accurately quantify the radiation absorbed by those patients ... success of this radiotherapy treatment has been available — that ... ...
(Date:7/5/2017)... 5, 2017   BioLife Solutions , Inc. (NASDAQ: ... marketer of proprietary clinical grade cell and tissue ... ("BioLife"), today announced that it has reached an agreement ... largest shareholder, to modify its existing credit facility effective ... modification, WAVI agreed to exchange its existing $4.25 million ...
Breaking Medicine Technology: